IMARC Group, a leading market research company, has recently releases report titled “Natural Killer Cells Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” the study provides a detailed analysis of the industry, including the global natural killer cells therapeutics market size, share, trends and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the natural killer cells therapeutics market?
The global natural killer cells therapeutics market size reached US$ 2.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2032, exhibiting a growth rate (CAGR) of 12.3% during 2024-2032.
Get a Sample Copy of this Report: https://www.imarcgroup.com/natural-killer-cells-therapeutics-market/requestsample
What is natural killer cells therapeutics?
Natural killer (NK) cells therapeutics are large granular lymphocytes that target multiple pathogenic antigens and reduce the risk of cytokine storms. They contain special proteins, such as proteases and perforin known as granzymes, that act as an essential component of the innate immune system and generate an immune response against malignancies and viral infections. At present, these therapies are gaining traction across the globe as professionals are developing several strategies such as ex vivo pre-conditioning with cytokines or small molecular drugs to improve the efficacy of NK cells therapeutics.
What are the growth prospects and trends in the natural killer cells therapeutics industry?
The market is primarily driven by the growing prevalence of chronic diseases, such as cancer, infectious diseases, and liver disorders. This can be attributed to unhealthy dietary patterns, lack of physical activities, and the increasing number of individuals consuming alcohol and tobacco products. In addition, the rising geriatric population that is more susceptible to cancer is contributing to the market growth.
Besides this, professionals are conducting clinical studies that focus on tumor-targeted antibody strategies to enhance the therapeutic benefit of NK-cell-based therapy while minimizing risks and toxicities. This, coupled with the introduction of novel methods and technologies that boost the immune response through allogeneic, off-the-shelf NK cell-based therapies, represents another major growth-inducing factor. Moreover, the rising product adoption to treat gastrointestinal diseases is further propelling the market growth.
Who are the key players operating in the industry?
The report covers the major market players including:
- Affimed GmbH
- Bristol-Myers Squibb Company
- Fate Therapeutics
- Fortress Biotech Inc.
- Glycostem Therapeutics
- Innate Pharma S.A.
- Kuur Therapeutics Inc. (Athenex Inc.)
- Nkarta Inc.
- Takeda Pharmaceutical Company Limited
- Ziopharm Oncology Inc.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Therapeutics:
- NK Cell Therapies
- NK Cell Directed Antibodies
Breakup by Application:
- Cancer
- Gastrointestinal Diseases
- Immunoproliferative Disorders
- Others
Breakup by End User:
- Hospitals
- Research Centers and Institutes
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=4214&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Media Contact:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
